These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36208275)

  • 21. The Role of Extracellular Vesicles in Bone Metastasis.
    Rossi M; Battafarano G; D'Agostini M; Del Fattore A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "Vesicular Intelligence" Strategy of Blood Cancers.
    Forte D; Barone M; Palandri F; Catani L
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33805807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cells.
    Strømme O; Psonka-Antonczyk KM; Stokke BT; Sundan A; Arum CJ; Brede G
    Exp Cell Res; 2019 Oct; 383(1):111490. PubMed ID: 31283912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The extracellular matrix: A key player in the pathogenesis of hematologic malignancies.
    Sidhu I; Barwe SP; Gopalakrishnapillai A
    Blood Rev; 2021 Jul; 48():100787. PubMed ID: 33317863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. piRNA-823 delivered by multiple myeloma-derived extracellular vesicles promoted tumorigenesis through re-educating endothelial cells in the tumor environment.
    Li B; Hong J; Hong M; Wang Y; Yu T; Zang S; Wu Q
    Oncogene; 2019 Jun; 38(26):5227-5238. PubMed ID: 30890754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies.
    Han L; Xu J; Xu Q; Zhang B; Lam EW; Sun Y
    Med Res Rev; 2017 Nov; 37(6):1318-1349. PubMed ID: 28586517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extracellular vesicle-mediated drug resistance in multiple myeloma].
    Yamamoto T; Yamamoto Y
    Rinsho Ketsueki; 2023; 64(9):1092-1098. PubMed ID: 37899187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of pim kinase as a target in multiple myeloma.
    Liu Z; Zhang Y; Guo Y; Wang H; Fu R
    Cancer Med; 2023 May; 12(10):11746-11759. PubMed ID: 37162273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal-Derived Extracellular Vesicles Suppress Proliferation of Bone Metastatic Cancer Cells Mediated by ERK2.
    Shupp AB; Neupane M; Agostini LC; Ning G; Brody JR; Bussard KM
    Mol Cancer Res; 2021 Oct; 19(10):1763-1777. PubMed ID: 34021072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles in Myeloid Neoplasms.
    Karantanou C; Minciacchi VR; Karantanos T
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Extracellular Vesicles in Hematological Malignancies.
    Raimondo S; Corrado C; Raimondi L; De Leo G; Alessandro R
    Biomed Res Int; 2015; 2015():821613. PubMed ID: 26583135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment.
    Parayath NN; Padmakumar S; Amiji MM
    Cancer Lett; 2020 Jul; 482():33-43. PubMed ID: 32289440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Vesicles and Hematopoietic Stem Cell Aging.
    Goldberg LR
    Arterioscler Thromb Vasc Biol; 2021 Aug; 41(8):e399-e416. PubMed ID: 34078091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria and the Tumour Microenvironment in Blood Cancer.
    Moore JA; Mistry JJ; Rushworth SA
    Adv Exp Med Biol; 2021; 1329():181-203. PubMed ID: 34664240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the Role and Utility of Extracellular Vesicles in Hematological Malignancies.
    Bazzoni R; Tanasi I; Turazzi N; Krampera M
    Stem Cells; 2022 Jul; 40(7):619-629. PubMed ID: 35442447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular vesicles of multiple myeloma cells utilize the proteasome inhibitor mechanism to moderate endothelial angiogenesis.
    Zarfati M; Avivi I; Brenner B; Katz T; Aharon A
    Angiogenesis; 2019 Feb; 22(1):185-196. PubMed ID: 30386953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
    Manier S; Kawano Y; Bianchi G; Roccaro AM; Ghobrial IM
    Curr Opin Hematol; 2016 Jul; 23(4):426-33. PubMed ID: 27101529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
    Klein B; Seckinger A; Moehler T; Hose D
    Recent Results Cancer Res; 2011; 183():39-86. PubMed ID: 21509680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research Progress of Intercellular Mitochondrial Transfer in the Development of Hematological Malignant Tumors --Review].
    Zhang LY; Xiang YH; Zhang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):310-313. PubMed ID: 35123645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in multiple myeloma.
    Vacca A; Ria R; Reale A; Ribatti D
    Chem Immunol Allergy; 2014; 99():180-96. PubMed ID: 24217610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.